Lord, Abbett & Co’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-34,443
Closed -$4.74M 580
2024
Q2
$4.74M Sell
34,443
-356,801
-91% -$49.1M 0.02% 468
2024
Q1
$54M Buy
391,244
+344,263
+733% +$47.5M 0.17% 161
2023
Q4
$6.19M Buy
+46,981
New +$6.19M 0.02% 439
2023
Q1
Sell
-2,598
Closed -$311K 614
2022
Q4
$311K Buy
+2,598
New +$311K ﹤0.01% 565
2020
Q2
Sell
-67,163
Closed -$5.81M 676
2020
Q1
$5.81M Sell
67,163
-15,943
-19% -$1.38M 0.03% 512
2019
Q4
$8.93M Sell
83,106
-11,355
-12% -$1.22M 0.03% 540
2019
Q3
$8.51M Buy
94,461
+157
+0.2% +$14.1K 0.03% 556
2019
Q2
$7.96M Buy
94,304
+36,477
+63% +$3.08M 0.03% 600
2019
Q1
$5.1M Buy
57,827
+1,443
+3% +$127K 0.02% 649
2018
Q4
$4.03M Sell
56,384
-3,019
-5% -$216K 0.01% 682
2018
Q3
$7.3M Buy
+59,403
New +$7.3M 0.02% 676
2016
Q4
Sell
-345,748
Closed -$17.5M 928
2016
Q3
$17.5M Sell
345,748
-99,139
-22% -$5.02M 0.05% 457
2016
Q2
$20.2M Buy
+444,887
New +$20.2M 0.06% 415
2016
Q1
Sell
-584,280
Closed -$33.1M 922
2015
Q4
$33.1M Buy
584,280
+56,098
+11% +$3.17M 0.1% 320
2015
Q3
$21M Sell
528,182
-40,000
-7% -$1.59M 0.06% 411
2015
Q2
$27.1M Sell
568,182
-419,402
-42% -$20M 0.07% 397
2015
Q1
$39.2M Buy
987,584
+753,717
+322% +$29.9M 0.1% 318
2014
Q4
$5.23M Sell
233,867
-87,921
-27% -$1.96M 0.01% 724
2014
Q3
$5.04M Buy
321,788
+5,420
+2% +$84.9K 0.01% 745
2014
Q2
$4.7M Buy
316,368
+79,227
+33% +$1.18M 0.01% 815
2014
Q1
$3.82M Buy
+237,141
New +$3.82M 0.01% 833
2013
Q3
Sell
-376,503
Closed -$5.04M 1078
2013
Q2
$5.04M Buy
+376,503
New +$5.04M 0.01% 801